JP2007533706A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007533706A5 JP2007533706A5 JP2007508906A JP2007508906A JP2007533706A5 JP 2007533706 A5 JP2007533706 A5 JP 2007533706A5 JP 2007508906 A JP2007508906 A JP 2007508906A JP 2007508906 A JP2007508906 A JP 2007508906A JP 2007533706 A5 JP2007533706 A5 JP 2007533706A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- ciclesonide
- dione
- diene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 claims description 8
- 229960003728 ciclesonide Drugs 0.000 claims description 8
- 238000011282 treatment Methods 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims 10
- 239000000825 pharmaceutical preparation Substances 0.000 claims 10
- 229940127557 pharmaceutical product Drugs 0.000 claims 10
- 239000000203 mixture Substances 0.000 claims 9
- -1 cyclohexylmethylene Chemical group 0.000 claims 6
- 208000006673 asthma Diseases 0.000 claims 4
- QIEPWCSVQYUPIY-LEKSSAKUSA-N Delta(1)-progesterone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 QIEPWCSVQYUPIY-LEKSSAKUSA-N 0.000 claims 3
- 239000003380 propellant Substances 0.000 claims 3
- 230000000391 smoking effect Effects 0.000 claims 3
- YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 claims 2
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 239000000443 aerosol Substances 0.000 claims 2
- 235000019504 cigarettes Nutrition 0.000 claims 2
- 239000006184 cosolvent Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 206010039083 rhinitis Diseases 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical group O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 claims 1
- 206010003557 Asthma exercise induced Diseases 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010014561 Emphysema Diseases 0.000 claims 1
- 208000004657 Exercise-Induced Asthma Diseases 0.000 claims 1
- 206010057190 Respiratory tract infections Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims 1
- 206010047924 Wheezing Diseases 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 206010006451 bronchitis Diseases 0.000 claims 1
- 125000000837 carbohydrate group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000024695 exercise-induced bronchoconstriction Diseases 0.000 claims 1
- 229960001021 lactose monohydrate Drugs 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 208000023504 respiratory system disease Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 238000011269 treatment regimen Methods 0.000 claims 1
- 208000011479 upper respiratory tract disease Diseases 0.000 claims 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
- 229960004436 budesonide Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56346404P | 2004-04-20 | 2004-04-20 | |
| PCT/EP2005/051718 WO2005102354A1 (en) | 2004-04-20 | 2005-04-19 | Use of ciclesonide for the treatment of respiratory diseases in a smoking patient |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007533706A JP2007533706A (ja) | 2007-11-22 |
| JP2007533706A5 true JP2007533706A5 (enExample) | 2012-08-09 |
Family
ID=34967481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007508906A Pending JP2007533706A (ja) | 2004-04-20 | 2005-04-19 | 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070134165A1 (enExample) |
| EP (1) | EP1740188A1 (enExample) |
| JP (1) | JP2007533706A (enExample) |
| AU (1) | AU2005235384B2 (enExample) |
| CA (1) | CA2563556C (enExample) |
| WO (1) | WO2005102354A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11007150B2 (en) | 2011-08-18 | 2021-05-18 | Covis Pharma Gmbh | Pharmaceutical aerosol product for administration by oral or nasal inhalation |
| RS57740B1 (sr) | 2012-12-21 | 2018-12-31 | Boehringer Ingelheim Vetmedica Gmbh | Ciklezonid za lečenje oboljenja disajnih puteva kod konja |
| EP2934544B1 (en) * | 2012-12-21 | 2018-11-07 | Boehringer Ingelheim Vetmedica GmbH | Pharmaceutical formulation comprising ciclesonide |
| LT3157522T (lt) | 2014-06-18 | 2019-11-25 | Boehringer Ingelheim Vetmedica Gmbh | Muskarininiai antagonistai ir jų deriniai, skirti arklių kvėpavimo takų ligos gydymui |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0039123B1 (en) * | 1980-02-27 | 1984-10-03 | TATE & LYLE PUBLIC LIMITED COMPANY | Crystalline glucose and process for its production |
| US4816445A (en) * | 1984-06-21 | 1989-03-28 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Crystalline alpha-maltose |
| JP2518646B2 (ja) * | 1987-05-29 | 1996-07-24 | 株式会社 林原生物化学研究所 | マルト−ス粉末の製造方法 |
| US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US6536427B2 (en) * | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
| US5178866A (en) * | 1990-03-23 | 1993-01-12 | Alza Corporation | Dosage form for delivering drug to the intestine |
| GR1001529B (el) * | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
| US5434304A (en) * | 1990-09-26 | 1995-07-18 | Aktiebolaget Astra | Process for preparing formoterol and related compounds |
| AU650953B2 (en) * | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
| US6866839B2 (en) * | 1991-04-05 | 2005-03-15 | Sepracor Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
| US5795564A (en) * | 1991-04-05 | 1998-08-18 | Sepracor, Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
| ATE134509T1 (de) * | 1991-06-10 | 1996-03-15 | Schering Corp | Fluorchlorkohlenwasserstoffreie aerosolformulierungen |
| IT1250691B (it) * | 1991-07-22 | 1995-04-21 | Giancarlo Santus | Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac. |
| ATE172739T1 (de) * | 1993-04-02 | 1998-11-15 | Byk Gulden Lomberg Chem Fab | Neue prednisolonderivate |
| US5811388A (en) * | 1995-06-07 | 1998-09-22 | Cibus Pharmaceutical, Inc. | Delivery of drugs to the lower GI tract |
| JPH11507670A (ja) * | 1995-06-12 | 1999-07-06 | ジー．ディー．サール アンド カンパニー | シクロオキシゲナーゼ−２インヒビターと５−リポキシゲナーゼインヒビターの組合せによる炎症と炎症関連疾患の治療 |
| CA2228953A1 (en) * | 1995-09-26 | 1997-04-03 | Takeda Chemical Industries, Ltd. | Phosphorylamides, their preparation and use |
| US6599927B2 (en) * | 1996-10-11 | 2003-07-29 | Astrazeneca Ab | Use of an H+, K+-ATPase inhibitor in the treatment of Widal's Syndrome |
| FR2754712B1 (fr) * | 1996-10-17 | 1999-09-03 | Merck Sharp Dohme Chibret Lab | Compositions ophtalmiques |
| US6613795B2 (en) * | 1996-11-11 | 2003-09-02 | Christian Noe | Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments |
| SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| US20020111495A1 (en) * | 1997-04-04 | 2002-08-15 | Pfizer Inc. | Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes |
| US6120752A (en) * | 1997-05-21 | 2000-09-19 | 3M Innovative Properties Company | Medicinal aerosol products containing formulations of ciclesonide and related steroids |
| GB2329939A (en) * | 1997-06-26 | 1999-04-07 | Glaxo Group Ltd | Self-lubricating valve stem for aerosol containers |
| SE9704186D0 (sv) * | 1997-11-14 | 1997-11-14 | Astra Ab | New composition of matter |
| ATE401312T1 (de) * | 1997-12-15 | 2008-08-15 | Astellas Pharma Inc | Pyrimidin-5-carboxamid-derivate |
| SE9801368D0 (sv) * | 1998-04-20 | 1998-04-20 | Astra Ab | New use |
| TWI243687B (en) * | 1998-04-21 | 2005-11-21 | Teijin Ltd | Pharmaceutical composition for application to mucosa |
| US6264923B1 (en) * | 1998-05-13 | 2001-07-24 | 3M Innovative Properties Company | Medicinal aerosol formulation of ciclesonide and related compounds |
| US6241969B1 (en) * | 1998-06-26 | 2001-06-05 | Elan Corporation Plc | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
| US6585958B1 (en) * | 1998-07-24 | 2003-07-01 | Jago Research Ag | Medicinal aerosol formulations |
| WO2000007567A1 (de) * | 1998-08-04 | 2000-02-17 | Jago Research Ag | Medizinische aerosolformulierungen |
| DK1131059T3 (da) * | 1998-11-13 | 2003-06-30 | Jago Res Ag | Tørpulver til inhalation |
| US6397838B1 (en) * | 1998-12-23 | 2002-06-04 | Battelle Pulmonary Therapeutics, Inc. | Pulmonary aerosol delivery device and method |
| US6124268A (en) * | 1999-02-17 | 2000-09-26 | Natreon Inc. | Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof |
| BR0009993A (pt) * | 1999-04-23 | 2002-01-08 | Battelle Memorial Institute | Pulverizador de aerossol eletrohidrodinâmico direcionalmente controlado, dispositivo para liberar gotìculas de aerossol eletricamente neutras, aparelho para liberar gotìculas de aerossol terapêuticas, processo para liberar gotìculas de aerossol, e, dispositivo para liberar aerossol |
| WO2000064591A1 (en) * | 1999-04-23 | 2000-11-02 | Battelle Memorial Institute | High mass transfer electrosprayer |
| AR026072A1 (es) * | 1999-10-20 | 2002-12-26 | Nycomed Gmbh | Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa |
| DE10062712A1 (de) * | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
| US20020183292A1 (en) * | 2000-10-31 | 2002-12-05 | Michel Pairet | Pharmaceutical compositions based on anticholinergics and corticosteroids |
| CA2427814C (en) * | 2000-11-07 | 2009-06-02 | Merck & Co., Inc. | A combination of a pde4 inhibitor and a leukotriene antagonist in the treatment of bronchial and respiratory disorders |
| MXPA03005697A (es) * | 2000-12-22 | 2003-10-06 | Glaxo Group Ltd | Inhalador de dosis medida para xinafoato de salmeterol. |
| MXPA04003879A (es) * | 2001-10-24 | 2005-02-17 | Pari Gmbh | Equipo para la preparacion de una composicion farmaceutica. |
| NZ532673A (en) * | 2001-11-17 | 2008-07-31 | Aventis Pharma Ltd | Package comprising a medicament, a component that gradually releases a gaseous substance and an adsorbent material |
| US20050020637A1 (en) * | 2001-11-19 | 2005-01-27 | Wolfgang-Alexander Simon | Agents for the treatment of airway disorders |
| ITMI20020808A1 (it) * | 2002-04-17 | 2003-10-17 | Chiesi Farma Spa | Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione |
| WO2004004739A1 (en) * | 2002-07-02 | 2004-01-15 | Altana Pharma Ag | Ciclesonide-containing sterile aqueous suspension |
| ES2452691T5 (es) * | 2003-09-16 | 2022-09-14 | Covis Pharma Gmbh | Uso de ciclesonida para el tratamiento de enfermedades respiratorias |
-
2005
- 2005-04-19 WO PCT/EP2005/051718 patent/WO2005102354A1/en not_active Ceased
- 2005-04-19 EP EP05742781A patent/EP1740188A1/en not_active Ceased
- 2005-04-19 CA CA2563556A patent/CA2563556C/en not_active Expired - Fee Related
- 2005-04-19 AU AU2005235384A patent/AU2005235384B2/en not_active Expired
- 2005-04-19 US US11/578,294 patent/US20070134165A1/en not_active Abandoned
- 2005-04-19 JP JP2007508906A patent/JP2007533706A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100523541B1 (ko) | 유기 화합물 | |
| EP1603565B1 (en) | Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients | |
| Edsbäcker et al. | Do airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids? | |
| NO328698B1 (no) | Anvendelse av mometasonfuroat for fremstilling av et torrpulverinhaleringsmedikament for behandling av sykdommer i de ovre eller nedre luftveier eller lunger | |
| CA2496699A1 (en) | Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids | |
| JP2007505829A5 (enExample) | ||
| JP2004500430A (ja) | ホルモテロール及びブデソニドを含有する医薬用の組み合わせ | |
| HRP20140257T1 (hr) | Uporaba ciklesonida za lijeäśenje bolesti dišnih puteva | |
| CN106470700A (zh) | 用于治疗copd的噻托溴铵、福莫特罗和布地奈德的组合 | |
| US20130125882A1 (en) | Method and composition for treating asthma and copd | |
| ES2426957T3 (es) | Procedimiento de tratamiento de rinosinusitis aguda | |
| JP2007533706A5 (enExample) | ||
| JP2007524698A5 (enExample) | ||
| JP2004500434A (ja) | サルメテロールとブデソニドを含む組合せ医薬 | |
| WO2005082413A2 (en) | Ciclesonide and glycopyrronium combination | |
| CN104271112A (zh) | 包含阿福特罗和糠酸氟替卡松的药物组合物 | |
| CN1306429A (zh) | 糖皮质类固醇在制备治疗轻度/早期c opd(慢性阻塞性肺病)的药物中的应用 | |
| US20070134165A1 (en) | Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient | |
| MXPA00009981A (en) | Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease) |